Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

AN2 Therapeutics, Inc.

1.22
-0.0200-1.61%
Post-market: 1.220.00000.00%17:39 EDT
Volume:52.53K
Turnover:64.43K
Market Cap:36.72M
PE:-0.71
High:1.24
Open:1.22
Low:1.21
Close:1.24
Loading ...
OverviewCompanyNewsFilings
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 21, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 04, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 14, 2018

Beneficial Ownership Change

Apr 27, 2018

Beneficial Ownership Change

Jan 22, 2018

Correspondence

Jan 22, 2018

[Amend]Public Prospectus

Jan 22, 2018

Correspondence

Jan 22, 2018

Correspondence

Jun 09, 2017

Correspondence

Jun 09, 2017

Correspondence

Jun 02, 2017

[Amend]Public Prospectus

Jun 02, 2017

Correspondence

May 18, 2017

[Amend]Public Prospectus

Jul 27, 2016

Business Combinations

企业合并披露
Jul 26, 2016

Business Combinations

企业合并披露
Jul 22, 2016

Business Combinations

企业合并披露
Jul 21, 2016

Business Combinations

企业合并披露
More

Analyst Rate

Hold
Buy
20.00%
Hold
60.00%
Sell
20.00%

Corporate Actions

no data

No relevant data is available

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.67
Current
-4.79
Sector Average
83.40%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.67
Maximum
-0.47
+1 STD
-0.85
Minimum
-16.37
-1 STD
-8.74
Average
-4.79

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.